San Diego, CA, United States of America

Angela Gaetano

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Companion Medical, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Angela Gaetano

Introduction

Angela Gaetano is an accomplished inventor based in San Diego, CA. She has made significant contributions to the field of medical technology, particularly in diabetes management. Her innovative work focuses on improving the lives of individuals who require insulin therapy.

Latest Patents

Angela holds a patent for a "Continuous glucose monitoring trend-enabled dose calculator." This invention discloses systems and methods for determining a dose of insulin that compensates for past carbohydrates consumed. It also adjusts for blood glucose (BG) trends as well as BG values. The invention aims to mitigate potential inaccuracies associated with double-counting or overcorrecting, applying safeguards to the determination of the insulin dose. Angela's patent is a testament to her dedication to enhancing diabetes care.

Career Highlights

Angela is currently employed at Companion Medical, Inc., where she continues to innovate in the medical technology sector. Her work at Companion Medical focuses on developing solutions that empower patients to manage their diabetes more effectively. With her expertise, she has become a valuable asset to her team.

Collaborations

Angela collaborates with her coworker, Jasper Benke, to further advance their projects and share insights in their field. Together, they work towards creating impactful solutions for diabetes management.

Conclusion

Angela Gaetano's contributions to medical technology, particularly through her patent for a continuous glucose monitoring trend-enabled dose calculator, highlight her commitment to improving patient care. Her work at Companion Medical, Inc. continues to pave the way for advancements in diabetes management.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…